clinical technologyとは 意味・読み方・使い方

Implementation of the PME technology has broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies, and has the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.例文帳に追加

PME技術を実施すると、臨床診断、法医学、および一般的な配列決定に日常的に使用できるように広く応用することができ、人口の大部分に対する標的配列変異アッセイ法に関して将来性、融通性、および可搬性を有する。 - 特許庁

Especially, also in the field in which practical realization of Japan-specialized technology is expected such as new immunoenhancing drugs and vaccines with new administration route, there is the crisis situation that clinical application and industrialization of Japanese technologies developed in national research institute, etc. are not progressed.例文帳に追加

特に、新たな免疫増強剤や新投与経路ワクチン等我が国が得意とする技術の実用化が期待される分野においても、国立研究機関等で開発された国産要素技術の臨床応用や産業化が進展していない危機的な状況がある。 - 厚生労働省

Furthermore, the second occasion of communication between the public and private sectors was held on April 26 2007. On this occasion of communication, we decided the “Five-Year Strategy for Creation of Innovative Pharmaceutical Products and Medical Devices” (the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry) composed of intensive infusion of research fund, fostering of venture companies, etc., arrangement of environment for clinical researches and clinical trials, cooperation with Asia, speed-up and quality improvement of regulatory review and proper rewarding of innovation.例文帳に追加

・ さらに、2007 年 4 月 26 日に 2 回目の官民対話を行い、この場で、研究資金の集中投入、ベンチャー企業の育成等、臨床研究・治験環境の整備、アジアとの連携、審査の迅速化・質の向上及びイノベーションの適切な評価からなる「革新的医薬品・医療機器創出のための５か年戦略」（文部科学省・厚生労働省・経済産業省）を決定したところである。 - 厚生労働省

This program will be implemented jointly by the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science and Technology in order to promote the development and modification of medical devices to meet needs and challenges in clinical medicine by using SMEs manufacturing technologies. More specifically, the quality of medical care in Japan will be raised and new fields of manufacturing business will be developed by accelerating the commercialization of medical devices employing SMEs’ manufacturing technologies. This will be achieved by means of the following: 1) Selection of research problems contributing to much-needed resolution of challenges in clinical medicine 2) Development and modification of medical devices by “medical-industrial partnerships” involving collaboration between SMEs possessing locally distinctive manufacturing technologies (cutting, precision machining, and coating technologies, etc.) with medical and research institutions facing challenges that could be solved using those technologies. 3) End-to-end initiatives extending from clinical evaluation to commercialization (Continuation) (See p. 204.)発音を聞く 例文帳に追加

中小企業のものづくり技術を活かして、医療現場の課題・ニーズに応える医療機器の開発・改良を促進するため、本事業では、厚生労働省及び文部科学省と連携し、①医療現場からのニーズが高く、課題解決に資する研究課題の選定② 地域の特色あるものづくり技術（切削、精密加工、コーティング等）を有する中小企業等と、それらの課題を有する医療機関や研究機関等とが連携した「医工連携」による医療機器の開発・改良　③臨床評価、実用化までの一貫した取組を行うことで、中小企業のものづくり技術を活かした医療機器の実用化を加速することにより、我が国における医療の質の向上と、ものづくり産業の新たな事業分野の開拓を実現する。（継続）（p.208 参照） - 経済産業省

The above mentioned items were also included as one of the goals in the "5-Year Strategy for the Creation of Innovative Pharmaceuticals and Medical Devices" (April 2007 Cabinet Office, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, and the Ministry of Economy, Trade and Industry) so that Japan, which has few natural resources, use its superior research and development abilities to participate in the global development and provision system of innovative pharmaceuticals and medical devices as well as expand the share of innovative pharmaceuticals and medical devices developed in Japan in the global market, thereby allowing the pharmaceutical and medical device industry to drive Japan's growth. Measures for the development of the clinical trial and clinical research environment required to realize this goal were set forth, and this 5-Year Plan plays an important part of these measures.例文帳に追加

上記の事項は、「革新的医薬品・医療機器創出のための５か年戦略」（平成19 年4 月 内閣府・文部科学省・厚生労働省・経済産業省）においても、天然資源の少ない我が国が、優れた研究開発力をもとに、革新的医薬品・医療機器の国際的開発・提供体制へ参加していくとともに、日本で開発される革新的医薬品・ 医療機器の世界市場におけるシェアを拡大することで、医薬品・医療機器産業を日本の成長牽引役へ導くことが目標のひとつとされ、その実現のために臨床研究・治験環境の整備を施策に掲げ、この５カ年計画がその施策の重要な部分を担っていることを示している。 - 厚生労働省